Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

FOUND: 28 | Mind Blowing Facts

Ex-McKinsey partner pleads guilty to destroying records on opioids

Martin Elling pleads guilty to destroying records on advice provided to Purdue Pharma on how to ‘turbocharge’ sales

The Guardian - US

Swinney: Consumption room should help reduce ‘entirely unacceptable’ drug deaths

The First Minister has visited the UK’s first facility where drug users can inject in a clean and safe environment.

Evening Standard

USTR warns of risks from online pharmacies in its 'notorious markets' report

An annual U.S. government report on “notorious markets” known for counterfeiting and other violations of intellectual property says that nearly all 35,000 online pharmacies around the world are being run illegally

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Blue-Chip Stocks with Strong Buy Ratings from Analysts

As a wave of volatility has been re-introduced to the system, investors are flocking toward blue-chip companies for stability and long-term growth potential. Thus, one could consider adding these three fundamentally sound blue-chip stocks, AbbVie (ABBV), Merck & Co. (MRK), and Johnson & Johnson (JNJ), with Strong Buy ratings from…

StockNews.com

Moderna Stock Is Volatile Amid Bird Flu Developments

Moderna stock has been volatile this week as the first death in the U.S. connected to bird flu was reported. Here's what you need to know.

Kiplinger

Wegovy maker Novo Nordisk sponsored British pharmacies in pursuit of sales

Danish drug company gave money for Google ads to promote weight loss services and received data on web traffic and prescriptions

The Guardian - UK

3 Specialty Pharma Stocks Addressing Unmet Medical Needs

The specialty pharma sector is leading the charge in developing life-changing solutions for rare and chronic conditions. Amid this backdrop, investors might consider adding three fundamentally solid specialty pharma stocks, namely, Ipsen S.A. (IPSEY), ACADIA Pharmaceuticals (ACAD), and Neurocrine Biosciences (NBIX) in their portfolios. Read on….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Judge in Luigi Mangione Case Married to Ex-Pfizer Executive, Owns Thousands in Healthcare Stock: Report

The judge presiding over pre-trial hearings for Luigi Mangione has come under scrutiny for her financial and familial ties to the healthcare industry.

Latin Times

AMD's 'Golden Rabbit' GPU reportedly hits 'end of life' status — Radeon RX 7900 GRE is no longer available at any retailer

Tweakers reports that several AMD add-in board partners confirmed the upper mid-range RX 7900 GRE is now declared "end-of-life" and is no longer being produced.

Tom’s Hardware

DOJ files complaint against CVS for facilitating unlawful sale of prescription opioids

The Justice Department has unsealed a civil complaint alleging CVS Pharmacy Inc. and various subsidiaries filled unlawful prescriptions in violation of the federal Controlled Substances Act

The Independent UK

3 High-Yield Dividend Stocks to Secure Before Year-End

Dividend-paying stocks provide investors with consistent income in turbulent markets, especially as payouts grow over time. Therefore, investors might consider adding dividend stocks, Pfizer (PFE), United Parcel Service (UPS), and Enterprise Products Partners (EPD) before year-end. Read more….

StockNews.com

Is Exelixis Positioned to Capitalize on Emerging Cancer Therapies?

In the expanding oncology market, Exelixis (EXEL) is gaining attention with its strong pipeline and impressive stock performance. With a clear focus on cancer treatment innovation and a growing market presence, is the company set to lead the future of cancer care and treatment? Read more….

StockNews.com

UnitedHealth chief admits US health system ‘does not work as well as it should’

In a New York Times essay, Andrew Witty also says slain healthcare CEO Brian Thompson cared about customers

The Guardian - US

McKinsey to pay $650m to resolve US investigation into opioid crisis role

Consultancy giant agrees to two criminal counts, including for conspiring with drug manufacturers, in DoJ settlement

The Guardian - US

Get all your
news in one place.

100's of premium titles.
One news app.

Top News

Mckinsey To Pay 0 Million In Purdue Pharma Settlement

McKinsey & Company agrees to pay 0 million in settlement for its role in Purdue Pharma's opioid crisis, impacting addiction and overdose prevention efforts.

The Independent UK

McKinsey & Company agrees to pay $650 million to settle federal probe over opioids work

McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in Virginia

StockNews.com

3 Healthcare Innovators Revolutionizing Patient Care

The healthcare sector is transforming with the adoption of digital technologies, improved productivity, and increasing R&D efforts. Thus, investors could consider quality healthcare innovator stocks Johnson & Johnson (JNJ), Merck & Co (MRK), and Bristol-Myers Squibb (BMY) as portfolio additions for potential gains. Continue reading.

The Independent UK

Vifor Pharma to pay £23m to NHS after competition probe into misleading claims

The competition watchdog was investigating whether the drugs firm had been spreading misleading information on a rival’s treatment.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Assessing Biogen: Insights From 19 Financial Analysts

Providing a diverse range of perspectives from bullish to bearish, 19 analysts have published ratings on Biogen (NASDAQ:BIIB) in the last three months.

International Business Times UK

Worker Reveals Shocking Reason Why Women Should Check The Toilet Paper When in Walmart Washrooms

Walmart employee warns women about IV drug users cleaning needles in toilet paper rolls, sparking public health concerns and fear.

Benzinga

Forecasting The Future: 5 Analyst Projections For NewAmsterdam Pharma

During the last three months, 5 analysts shared their evaluations of NewAmsterdam Pharma (NASDAQ:NAMS), revealing diverse outlooks from bullish to bearish.

Benzinga

4 Analysts Assess Amylyx Pharma: What You Need To Know

During the last three months, 4 analysts shared their evaluations of Amylyx Pharma (NASDAQ:AMLX), revealing diverse outlooks from bullish to bearish.

Benzinga

Warren Buffett's Portfolio Stock Kroger Pauses Buybacks For Albertsons Merger, Narrows FY24 Outlook

Kroger pauses share buybacks for the Albertsons merger, misses Q3 sales estimates, and narrows its FY24 EPS guidance.

Benzinga

Why Verint Systems Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket

Shares of Verint Systems Inc. (NASDAQ:VRNT) rose sharply in today's pre-market trading after the company reported a year-over-year increase in third-quarter financial results.

Benzinga

Danish Medical Marijuana Producer Stenocare To Launch Patented 10mg THC And 10mg CBD Oil In Norway

A publicly traded Danish medical marijuana operator Stenocare announced Monday the approval of its innovative product, Astrum 10-10, for sale in Norway. This milestone paves the way for more patients to access the benefits of medical cannabis treatment. Astrum 10-10 is expected to become available to patients within the next…

1 … 27 28 29 30

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

Read news from The Economist, FT, and more,
with one subscription

Topics

Intellectual Property

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.